CA3060219A1 - Secretion-competent muteins of the human il-27 alpha-subunit - Google Patents

Secretion-competent muteins of the human il-27 alpha-subunit Download PDF

Info

Publication number
CA3060219A1
CA3060219A1 CA3060219A CA3060219A CA3060219A1 CA 3060219 A1 CA3060219 A1 CA 3060219A1 CA 3060219 A CA3060219 A CA 3060219A CA 3060219 A CA3060219 A CA 3060219A CA 3060219 A1 CA3060219 A1 CA 3060219A1
Authority
CA
Canada
Prior art keywords
subunit
human interleukin
mutein
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3060219A
Other languages
English (en)
French (fr)
Inventor
Matthias Feige
Stephanie Mueller
Original Assignee
Technische Universitaet Muenchen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technische Universitaet Muenchen filed Critical Technische Universitaet Muenchen
Publication of CA3060219A1 publication Critical patent/CA3060219A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA3060219A 2017-05-04 2018-05-04 Secretion-competent muteins of the human il-27 alpha-subunit Pending CA3060219A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17169358.3 2017-05-04
EP17169358 2017-05-04
PCT/EP2018/061561 WO2018202876A1 (en) 2017-05-04 2018-05-04 Secretion-competent muteins of the human il-27 alpha-subunit

Publications (1)

Publication Number Publication Date
CA3060219A1 true CA3060219A1 (en) 2018-11-08

Family

ID=58669684

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3060219A Pending CA3060219A1 (en) 2017-05-04 2018-05-04 Secretion-competent muteins of the human il-27 alpha-subunit

Country Status (7)

Country Link
US (1) US11358998B2 (https=)
EP (1) EP3619228A1 (https=)
JP (1) JP7249955B2 (https=)
CN (1) CN110709413B (https=)
AU (1) AU2018262811B2 (https=)
CA (1) CA3060219A1 (https=)
WO (1) WO2018202876A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7641912B2 (ja) 2019-04-19 2025-03-07 シナーキン・ファーマ・ベスローテン・フエンノートシャップ Ｉｌ１３を含む融合タンパク質
US20220380426A1 (en) * 2019-11-12 2022-12-01 Technische Universitat Mu Homogeneous muteins of the human il-27 alpha-subunit
CN113307861A (zh) * 2020-12-09 2021-08-27 重庆医科大学 细胞因子il-27作为nec与fpies鉴别诊断标志物及应用
WO2024213695A1 (en) * 2023-04-14 2024-10-17 Technische Universitaet Muenchen Method for producing the subunits of human interleukin 35 from interleukin 12 and interleukin 27
CN116832146B (zh) * 2023-06-30 2024-02-13 广东暨安特博生物科技有限公司 Il-27蛋白在制备治疗阿尔茨海默症的产品的应用
WO2025140436A1 (zh) * 2023-12-27 2025-07-03 上海药明生物技术有限公司 重组il-27蛋白及其制备方法
WO2025252853A1 (en) * 2024-06-04 2025-12-11 Technische Universitaet Muenchen, In Vertretung Des Freistaates Bayern Fusion-polypeptide comprising a mutein of the alpha-subunit of human il-27 and at least one pharmaceutically acceptable fusion partner

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4839434B2 (ja) * 2005-03-14 2011-12-21 千葉県 ｐ２８分子またはその遺伝子を含む医薬製剤
EP2831100A4 (en) * 2012-03-26 2016-02-10 Pronutria Inc NUTRIENT PROTEINS AND METHOD

Also Published As

Publication number Publication date
CN110709413B (zh) 2023-11-28
JP2020518249A (ja) 2020-06-25
JP7249955B2 (ja) 2023-03-31
AU2018262811B2 (en) 2021-10-21
WO2018202876A1 (en) 2018-11-08
EP3619228A1 (en) 2020-03-11
US20200062817A1 (en) 2020-02-27
AU2018262811A1 (en) 2019-12-19
US11358998B2 (en) 2022-06-14
CN110709413A (zh) 2020-01-17

Similar Documents

Publication Publication Date Title
US11358998B2 (en) Cretion-competent muteins of the human IL-27 alpha-subunit
Metcalfe et al. Structural understanding of interleukin 6 family cytokine signaling and targeted therapies: focus on interleukin 11
JP7372036B2 (ja) Ｔ細胞調節多量体ポリペプチド及びその使用方法
Müller et al. A folding switch regulates interleukin 27 biogenesis and secretion of its α-subunit as a cytokine
JP6580037B2 (ja) 高度に低下された受容体結合親和性を有するサイトカインを含むフソカイン
JP2021097697A (ja) フォリスタチン関連融合タンパク質およびその使用
IL321567A (en) Il-2 orthologs and methods of use
EP2161287A1 (en) OPTIMIZED TACI-Fc FUSION PROTEINS
Kim et al. Site-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein
CN103370339A (zh) 多聚体il-15可溶性融合分子与其制造与使用方法
Guo et al. Protection against Th17 cells differentiation by an interleukin-23 receptor cytokine-binding homology region
CN109790526A (zh) 优化的二核酸酶融合体和方法
Müller et al. An interspecies analysis reveals molecular construction principles of interleukin 27
Belladonna et al. Bioengineering heterodimeric cytokines: turning promiscuous proteins into therapeutic agents
Babaki et al. Mycobacterium tuberculosis Ag85b: hfcγ1 recombinant fusion protein as a selective receptor-dependent delivery system for antigen presentation
JP2023506956A (ja) Ｉｌ－３７融合タンパク質及びその使用
JP2013529900A (ja) Ｂ細胞活性化因子の拮抗物質、その調製方法及び利用法
US20220380426A1 (en) Homogeneous muteins of the human il-27 alpha-subunit
Darabi et al. Codon optimization, cloning and expression of the human Leukemia Inhibitory Factor (hLIF) in E. coli
Huang et al. A novel strategy to produce high level and high purity of bioactive IL15 fusion proteins from mammalian cells
EP1945663B1 (en) Insulin-like growth factor ii (igf-ii) binding factors
Wang et al. Rational and efficient preparation of a chimeric protein containing a tandem dimer of thrombopoietin mimetic peptide fused to human growth hormone in Escherichia coli
Lee et al. High-yield production of recombinant CLCF1 protein fused with human serum albumin in animal cells and toxicity evaluation in rodents
CN113195522A (zh) 包含人类Lefty A蛋白变体的融合蛋白及其用途
Müller Folding and quality control of the interleukin 12 family cytokines interleukin 27 and interleukin 35

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220819

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250214

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - SMALL

Year of fee payment: 7

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250402

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250402

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20250612

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250617

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250723

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250723

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - SMALL

Year of fee payment: 8

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260401

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260401